+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Vascular Patches Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 5176092
  • Report
  • August 2020
  • Region: Global
  • 112 Pages
  • Mordor Intelligence


  • Admedus
  • B. Braun Melsungen AG
  • Baxter International
  • C. R. Bard (BD)
  • Cryolife
  • Edwards Lifesciences
The growth of the vascular patches market is due to the benefits linked with stenosis or occlusion of blood vessels. Presently, the autologous vessels, like the saphenous vein and internal thoracic artery, are the gold standard for several vascular surgeries. The present trend involves a significant demand for synthetic vascular patches, due to the presence of well-established polymeric biomaterials companies across several countries, globally.
  • The application segment is majorly surrounded around cardiovascular diseases. The high prevalence of stroke and ischemic heart diseases, leading to a large number of hospital admissions, leads to a higher demand for vascular patch use in hospitals. A large number of carotid endarterectomies are performed globally, and it is considered as a well-established procedure across multiple hospitals, which primarily demands the use of vascular patches.

Key Market Trends

The Aortic Aneurysms Segment is Expected to Exhibit the Fastest Growth Rate over the Forecast Period

Pseudoaneurysm of the ascending aorta is a rare but potentially fatal complication after cardiovascular surgery, and it can result in a rupture. A small, localized saccular pseudoaneurysm of the aorta is often treated with quick patch repair rather than tube graft replacement.

As per a 2019 report by Ronald L Dalman et al., certain forms of aortic aneurysm like abdominal aortic aneurysm (AAA) are uncommon among people under the age of 60 years. About 1 person in 1000 develops AAA between the ages of 60 and 65 years, and this number continues to rise with age. The report also observes that AAAs occur in up to 13% of men and 6% of women over the age of 65 years. Moreover, the global geriatric population is also on the rise, especially in developed regions of the world. For instance, in the United States, the population aged 60 years and above is expected to increase from 21.5% in 2017 to 27.8% by 2050. This factor is also expected to increase the incidence of aortic aneurysm, which will increase the demand for vascular patches, helping in the market growth.

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America holds the largest share in the vascular patches market, with the United States being the largest contributor to its revenue. The United States spends a significant percentage of its GDP on healthcare, each year. According to the recent report of the Organization for Economic Co-operation and Development (OECD), 2018, about 18% of the GDP is spent on healthcare. This has driven the research and development in the region and also promoted awareness regarding vascular patches.

Additionally, the increasing prevalence of vascular diseases is the major factor expected to drive the overall growth of the market, during the forecast period. Furthermore, there is a rise in the geriatric population in the United States, which is expected to create more opportunities for the market in the country.

Competitive Landscape

The vascular patches market is highly competitive and consists of several major players. The presence of major market players, such as Terumo Corporation, Baxter International, Getinge AB (Maquet), B. Braun Melsungen AG, and Becton, Dickinson, and Company are, in turn, increasing the overall competitive rivalry of the market.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown


  • Admedus
  • B. Braun Melsungen AG
  • Baxter International
  • C. R. Bard (BD)
  • Cryolife
  • Edwards Lifesciences

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Rapidly Growing Geriatric Population and Increase in the Prevalence of Vascular Diseases
4.3.2 Increasing Adoption of Biological Patches
4.4 Market Restraints
4.4.1 Risk of Immune Response and Serious Complications
4.4.2 Product Failures and Recalls
4.5 Industry Attractiveness - Porter's Five Forces Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers/Consumers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry
5.1 By Material
5.1.1 Biologic Vascular Patches
5.1.2 Synthetic Vascular Patches
5.2 By Application
5.2.1 Carotid Endarterectomy
5.2.2 Aortic Aneurysms
5.2.3 Profundaplasty
5.2.4 Other Applications
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe United Kingdom Germany France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Lemaitre Vascular
6.1.2 Baxter International
6.1.3 Getinge AB (Maquet)
6.1.4 B. Braun Melsungen AG
6.1.5 W. L. Gore & Associates
6.1.6 Admedus
6.1.7 Cryolife
6.1.8 C. R. Bard (BD)
6.1.9 Edwards Lifesciences
6.1.10 Terumo Corporation
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Lemaitre Vascular
  • Baxter International
  • Getinge AB (Maquet)
  • B. Braun Melsungen AG
  • W. L. Gore & Associates
  • Admedus
  • Cryolife
  • C. R. Bard (BD)
  • Edwards Lifesciences
  • Terumo Corporation
Note: Product cover images may vary from those shown